Examinations
Examinations
Excess body weight (Body Mass Index > 25 kg/m²) | Close relatives with diabetes mellitus | Women with a history of pregnancy complications such as preterm birth, excessive birth weight (over 4.5 kg), congenital anomalies, or stillbirths |
Patients over 45 years old | Metabolic syndrome | Chronic liver diseases |
Atherosclerosis, gout | Polycystic ovary syndrome (PCOS) | Neuropathies of unknown etiology |
Long-term use of diuretics, glucocorticoids, and synthetic estrogens | Chronic periodontitis and furunculosis | Low physical activity |
History of fasting hyperglycemia or impaired glucose tolerance | Arterial hypertension of various origins and different cardiovascular diseases | Disorders of lipid metabolism: HDL < 0.9 mmol/L, triglycerides > 2.82 mmol/L |
Repeating the test is not appropriate if the blood glucose concentration exceeds the diagnostic threshold (7 mmol/L). The test is contraindicated in patients with fasting glucose levels above 11 mmol/L, including those who have recently undergone surgery, experienced myocardial infarction, or given birth. On a physician’s recommendation, the test may be performed to evaluate the secretory reserve of insulin by measuring C-peptide in the fasting state and insulin levels 2 hours after glucose loading.
Diagnostic criteria for diabetes mellitus and other glycaemic disorders (WHO, 1999-2013).
Examination time | Glucose concentration (venous plasma), mmol/l |
Normal values | |
Fasting: | < 6.1 mmol/L |
2 hours after OGTT: | < 7.8 mmol/L |
Diabetes mellitus | |
Fasting: | ≥ 7.0 mmol/L |
2 hours after OGTT: | ≥ 11.1 mmol/L |
Impaired glucose tolerance | |
Fasting: | < 7.0 mmol/L |
2 hours after OGTT: | ≥ 7.8 and < 11.1 mmol/L |
Impaired fasting glycemia | |
Fasting: | ≥ 6.1 and < 7.0 mmol/L |
2 hours after OGTT: | < 7.8 mmol/L |
Gestational diabetes mellitus | |
Fasting: | ≥ 5.1 and < 7.0 mmol/L |
2 hours after OGTT: | ≥ 8.5 and < 11.1 mmol/L |
Causes of Impaired Glucose Tolerance:
Increased tolerance | Decreased tolerance |
Reduced rate of intestinal absorption: | Increased Rate of Intestinal Glucose Absorption: |
- Hypocortisolism | - Excess dietary glucose intake |
- Hypopituitarism with secondary adrenal insufficiency | - Hyperthyroidism |
- Intestinal diseases (steatorrhea, sprue, tuberculous enteritis, Whipple’s disease) | - Post-gastrectomy, post-gastroenterostomy, and post-vagotomy states |
- Hypothyroidism | - Duodenal ulcer |
Excess insulin secretion: | Increased Glycogenolysis and Gluconeogenesis: |
- Insulinoma | - Hyperthyroidism |
-Nesidioblastoma | - Emotional stress or adrenal hyperfunction associated with pheochromocytoma |
- Infection-related toxemia | |
- Pregnancy | |
Impaired Glycogen Formation from Absorbed Glucose: | |
- Liver damage | |
- Glycogen storage diseases (glycogenosis) | |
Impaired Peripheral Utilization of Glucose by Tissues: | |
- Pre-diabetes, diabetes mellitus, steroid-induced diabetes | |
- Brain trauma and intracranial processes involving damage or compression of the hypothalamic region. In such cases, glucose levels may be abnormally elevated and then gradually return toward fasting levels. |
The double glucose load test (Staub-Traugott test), intravenous glucose test, and cortisone and prednisolone-glucose tests allow assessment of carbohydrate metabolism status and, in some cases, help detect its early disturbances. However, these tests cannot be used to confirm the diagnosis of diabetes mellitus, as there are no officially standardized evaluation criteria for them.
Examinations